{"organizations": [], "uuid": "77d7598e6fb2cd7dcb5b8b08e8732b228400032e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "blogs.wsj.com", "main_image": "http://si.wsj.net/public/resources/images/BN-DP087_0708sh_P_20140708114859.jpg", "site_section": "http://blogs.wsj.com/moneybeat/feed/", "section_title": "MoneyBeat", "url": "https://blogs.wsj.com/moneybeat/2018/04/19/wsj-city-pm-shires-shares-jump-after-42-billion-takeda-bid-whats-next-for-the-saudi-russia-oil-pact/", "country": "US", "domain_rank": 387, "title": "WSJ City PM: Shire Faces Bidding Battle After £42 Billion Takeda Offer, What’s Next for the Saudi-Russia Oil Pact?", "performance_score": 0, "site": "wsj.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "blogs", "published": "2018-04-19T18:43:00.000+03:00", "replies_count": 0, "uuid": "77d7598e6fb2cd7dcb5b8b08e8732b228400032e"}, "author": "Darren Lazarus", "url": "https://blogs.wsj.com/moneybeat/2018/04/19/wsj-city-pm-shires-shares-jump-after-42-billion-takeda-bid-whats-next-for-the-saudi-russia-oil-pact/", "ord_in_thread": 0, "title": "WSJ City PM: Shire Faces Bidding Battle After £42 Billion Takeda Offer, What’s Next for the Saudi-Russia Oil Pact?", "locations": [], "entities": {"persons": [], "locations": [{"name": "london", "sentiment": "none"}, {"name": "u.s.", "sentiment": "none"}, {"name": "shire", "sentiment": "none"}, {"name": "us", "sentiment": "none"}], "organizations": [{"name": "wsj city", "sentiment": "negative"}, {"name": "eu", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Good afternoon from the WSJ City desks in London. WSJ City is the app that delivers concise, smart news on business and finance for mobile. Download for iPhone or Android. Here’s essential reading on today’s developments. MUST READS FROM WSJ CITY Shares in Shire rose 5.6% after a potential bidding war broke out for the Dublin-headquartered drugmaker. US rival Allergan   Brexit & Beyond:EU Drafts Peace Offer to U.S. Over Tariffs Next Growth in Banks' ROEs Gets Boost From New Tax Law", "external_links": [], "published": "2018-04-19T18:43:00.000+03:00", "crawled": "2018-04-19T20:32:11.001+03:00", "highlightTitle": ""}